Oct. 23 at 1:04 PM
$INBS growing micro cap in play on new order of its finger print drug test "Multinational company employs approximately 3,000 staff within the UK and Ireland and more than 30,000 staff worldwide
Large new customer account highlights accelerating adoption of the Company's rapid, non-invasive drug testing technology across high-volume, safety-critical sectors...The customer's existing testing process, based on urine collection and third-party testing, was identified as slow and operationally disruptive. By transitioning to INBS's Intelligent Fingerprinting Drug Screening System, the customer expects to achieve faster, cleaner, and more efficient testing that reduces downtime, increases productivity, and delivers rapid results at point of testing. Strong internal support reinforced the transition decision, with stakeholders highlighting the benefits of a less invasive method, improved employee experience, and shorter detection windows. " https://finviz.com/news/201968/intelligent-bio-solutions-secures-major-uk-contract-with-multinational-industrial-service-provider working on approval in US,
